Bridging the Gap in IgM Therapy: A Novel Protocol-Based Approach in Critical Care Setting

Khaled Sewify; Ahmad Elsayed; Mohamed Sewify; Abdelaziz Alshaer; Wael Gomaa; Eslam Abdelshafey; Omar Alzuwayed; Hani Hosny; Ahmed Abu Alsaud

doi:10.36948/ijfmr.2025.v07i06.63867

Bridging the Gap in IgM Therapy: A Novel Protocol-Based Approach in Critical Care Setting

Author(s)	Dr. Khaled Sewify, Ahmad Elsayed, Mohamed Sewify, Abdelaziz Alshaer, Wael Gomaa, Eslam Abdelshafey, Omar Alzuwayed, Hani Hosny, Ahmed Abu Alsaud
Country	Saudi Arabia
Abstract	Background: The use of IgM-enriched immunoglobulin (Pentaglobin) in critical care settings demands thorough understanding about its pharmacokinetic properties and metabolic processes. The biochemical processes which determine the best treatment protocols and patient selection criteria for this medication have not received sufficient study. Objective: To develop a protocol-based methodology framework to integrate pharmacokinetic principles with metabolic pathway analysis for implementing IgM-enriched immunoglobulin therapy in critical care settings to enhance patient results and treatment optimization. Methods: We studied all available clinical protocols and pharmacokinetic data and metabolic pathway research about IgM-enriched immunoglobulin therapy. The evidence synthesis evaluated current critical care literature from 2018 to 2025 to determine dosing algorithms and biomarker-based selection criteria and outcome monitoring protocols. Results: The pharmacokinetic profile of IgM-enriched immunoglobulin shows distinct distribution patterns which differ from standard immunoglobulin products thus affecting how often and long patients need treatment. The metabolic pathway shows multiple complex interactions between the complement system and opsonization processes and reticuloendothelial clearance systems which affect treatment outcomes. The treatment protocol needs individualized patient assessment through phenotyping based on inflammatory markers and immune status evaluation and organ dysfunction severity determination. Conclusions: The methodology establishes a systematic method for IgM-enriched immunoglobulin therapy implementation which combines pharmacokinetic principles with metabolic pathway analysis to achieve best patient’s outcome in critical care settings.
Keywords	IgM-enriched immunoglobulin, pharmacokinetics, metabolic pathways, critical care protocols, immunomodulation, sepsis therapy
Field	Medical / Pharmacy
Published In	Volume 7, Issue 6, November-December 2025
Published On	2025-12-22
DOI	https://doi.org/10.36948/ijfmr.2025.v07i06.63867

View / Download PDF File

E-ISSN 2582-2160

doi

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads

Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 8 Isu 2 Cover Page Vol 8 Isu 1 Cover Page Vol 7 Isu 6

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA

About IJFMR Fees & Payment Current Issue Publication Archive	Submit Research Paper Track Submission Status Publication Guidelines Publication Ethics Peer Review & Plagiarism	Join as a Reviewer Editors & Reviewers Reviewer Referral Program Get Reviewer Membership Certi.	Website/Journal Policies Usage Policy Content Policies Privacy Policy

Contact Us		+91-9687-828-838	editor@ijfmr.com

International Journal For Multidisciplinary Research

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Bridging the Gap in IgM Therapy: A Novel Protocol-Based Approach in Critical Care Setting

Share this